Financhill
Sell
17

OGI Quote, Financials, Valuation and Earnings

Last price:
$1.56
Seasonality move :
20.35%
Day range:
$1.44 - $1.61
52-week range:
$1.22 - $2.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.16x
P/B ratio:
0.87x
Volume:
1.1M
Avg. volume:
855.8K
1-year change:
27.87%
Market cap:
$196.8M
Revenue:
$117.5M
EPS (TTM):
-$0.41
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $119.8M $117.5M
Revenue Growth (YoY) -- -- -- 4.53% -1.92%
 
Cost of Revenues -- -- -- $91.6M $82.5M
Gross Profit -- -- -- $28.2M $34.9M
Gross Profit Margin -- -- -- 23.51% 29.73%
 
R&D Expenses -- -- -- $9.8M $8.2M
Selling, General & Admin -- -- -- $53.4M $50.1M
Other Inc / (Exp) -- -- -- -$147.9M -$7.2M
Operating Expenses -- -- -- $67.3M $61.1M
Operating Income -- -- -- -$39.2M -$26.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$187M -$33.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$2.8M --
Net Income to Company -- -- -- -$184.2M -$33.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$184.2M -$33.4M
 
Basic EPS (Cont. Ops) -- -- -- -$2.27 -$0.35
Diluted EPS (Cont. Ops) -- -- -- -$2.27 -$0.35
Weighted Average Basic Share -- -- -- $81.3M $95.3M
Weighted Average Diluted Share -- -- -- $81.3M $95.3M
 
EBITDA -- -- -- -$19.8M -$17.3M
EBIT -- -- -- -$39.2M -$26.2M
 
Revenue (Reported) -- -- -- $119.8M $117.5M
Operating Income (Reported) -- -- -- -$39.2M -$26.2M
Operating Income (Adjusted) -- -- -- -$39.2M -$26.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $32.8M
Revenue Growth (YoY) -- -- -- -- 35.73%
 
Cost of Revenues -- -- -- -- $20.1M
Gross Profit -- -- -- -- $12.6M
Gross Profit Margin -- -- -- -- 38.52%
 
R&D Expenses -- -- -- -- $1.2M
Selling, General & Admin -- -- -- -- $10.5M
Other Inc / (Exp) -- -- -- -- -$4.3M
Operating Expenses -- -- -- -- $12.4M
Operating Income -- -- -- -- $207.4K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- -$4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $22K
Net Income to Company -- -- -- -- -$4.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- -$4M
 
Basic EPS (Cont. Ops) -- -- -- -- -$0.07
Diluted EPS (Cont. Ops) -- -- -- -- -$0.07
Weighted Average Basic Share -- -- -- -- $69.4M
Weighted Average Diluted Share -- -- -- -- $69.4M
 
EBITDA -- -- -- -- $5.3M
EBIT -- -- -- -- $3.1M
 
Revenue (Reported) -- -- -- -- $32.8M
Operating Income (Reported) -- -- -- -- $207.4K
Operating Income (Adjusted) -- -- -- -- $3.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $117.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $82.5M
Gross Profit -- -- -- -- $34.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- $8.2M
Selling, General & Admin -- -- -- -- $50.1M
Other Inc / (Exp) -- -- -- -- -$7.3M
Operating Expenses -- -- -- -- $61.2M
Operating Income -- -- -- -- -$26.3M
 
Net Interest Expenses -- -- -- -- $121.4K
EBT. Incl. Unusual Items -- -- -- -- -$33.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$300
Net Income to Company -- -- -- -- -$33.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- -$33.6M
 
Basic EPS (Cont. Ops) -- -- -- -- -$0.41
Diluted EPS (Cont. Ops) -- -- -- -- -$0.41
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- -$17.5M
EBIT -- -- -- -- -$26.4M
 
Revenue (Reported) -- -- -- -- $117.4M
Operating Income (Reported) -- -- -- -- -$26.3M
Operating Income (Adjusted) -- -- -- -- -$26.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $62.5M $114.4M $85.5M $117.4M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $84.3M $89.7M $64M $82.5M --
Gross Profit -$21.7M $24.7M $21.5M $34.9M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.9M $4.7M $6.8M $8.2M --
Selling, General & Admin $36.7M $46.5M $37.5M $50.1M --
Other Inc / (Exp) -$43M $19.6M -$133.8M -$7.3M --
Operating Expenses $35.1M $55.2M $47.4M $61.2M --
Operating Income -$56.9M -$30.5M -$25.9M -$26.3M --
 
Net Interest Expenses $2.3M $336.3K $124.2K $121.5K --
EBT. Incl. Unusual Items -$102.2M -$11.2M -$159.8M -$33.6M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$65.9K -$1.1M -$260 --
Net Income to Company -$103M -$11.2M -$158.7M -$33.4M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$102.2M -$11.2M -$158.7M -$33.6M --
 
Basic EPS (Cont. Ops) -$1.70 -$0.23 -$0.52 -$0.41 --
Diluted EPS (Cont. Ops) -$1.70 -$0.23 -$0.52 -$0.41 --
Weighted Average Basic Share $255.4M $316.3M $236.9M $346.2M --
Weighted Average Diluted Share $255.7M $316.3M $236.9M $350.2M --
 
EBITDA -$75.3M $8.7M -$144.4M -$17.5M --
EBIT -$99.9M -$10.9M -$159.7M -$26.4M --
 
Revenue (Reported) $62.5M $114.4M $85.5M $117.4M --
Operating Income (Reported) -$56.9M -$30.5M -$25.9M -$26.3M --
Operating Income (Adjusted) -$99.9M -$10.9M -$159.7M -$26.4M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- $24.9M $79M
Short Term Investments -- -- -- $373.7K $987.4K
Accounts Receivable, Net -- -- -- $20.2M $24.2M
Inventory -- -- -- $59.6M $61.1M
Prepaid Expenses -- -- -- $8.1M $6.7M
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $114.7M $194.1M
 
Property Plant And Equipment -- -- -- $72.9M $71.2M
Long-Term Investments -- -- -- $10.5M $30.2M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- $7.8M $6M
Other Long-Term Assets -- -- -- $13.2M --
Total Assets -- -- -- $219.6M $301.9M
 
Accounts Payable -- -- -- $14.7M $34.9M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- $55.9K $44.4K
Current Portion Of Capital Lease Obligations -- -- -- $745.2K $759.4K
Other Current Liabilities -- -- -- $846.8K $3.8M
Total Current Liabilities -- -- -- $16.5M $39.5M
 
Long-Term Debt -- -- -- $58.1K $18.5K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $19.7M $75.4M
 
Common Stock -- -- -- $571.5M $631.3M
Other Common Equity Adj -- -- -- $24.5M $27.4M
Common Equity -- -- -- $199.8M $226.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $199.8M $226.5M
 
Total Liabilities and Equity -- -- -- $219.6M $301.9M
Cash and Short Terms -- -- -- $25.3M $80M
Total Debt -- -- -- $114K $62.9K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $79M
Short Term Investments -- -- -- -- $987.4K
Accounts Receivable, Net -- -- -- -- $24.2M
Inventory -- -- -- -- $61.1M
Prepaid Expenses -- -- -- -- $6.7M
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- -- $194.1M
 
Property Plant And Equipment -- -- -- -- $71.2M
Long-Term Investments -- -- -- -- $30.2M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- $6M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- $301.9M
 
Accounts Payable -- -- -- -- $34.9M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- $44.4K
Current Portion Of Capital Lease Obligations -- -- -- -- $759.4K
Other Current Liabilities -- -- -- -- $3.8M
Total Current Liabilities -- -- -- -- $39.5M
 
Long-Term Debt -- -- -- -- $18.5K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $75.4M
 
Common Stock -- -- -- -- $631.3M
Other Common Equity Adj -- -- -- -- $27.4M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $226.5M
 
Total Liabilities and Equity -- -- -- -- $301.9M
Cash and Short Terms -- -- -- -- $80M
Total Debt -- -- -- -- $62.9K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$184.2M -$33.4M
Depreciation & Amoritzation -- -- -- $19.4M $8.9M
Stock-Based Compensation -- -- -- $4.2M $5.3M
Change in Accounts Receivable -- -- -- $10M -$8.9M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$28.7M $2.8M
 
Capital Expenditures -- -- -- $22.5M $3.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- $3.7M -$28.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$620.2K -$577.6K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$14.1K --
Cash From Financing -- -- -- -$605.4K $79.2M
 
Beginning Cash (CF) -- -- -- $50.8M $24.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$25.7M $53.6M
Ending Cash (CF) -- -- -- $25.1M $78.4M
 
Levered Free Cash Flow -- -- -- -$51.3M -$1.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$4.2M
Depreciation & Amoritzation -- -- -- -- $2.3M
Stock-Based Compensation -- -- -- -- $829.1K
Change in Accounts Receivable -- -- -- -- $143.8K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- $6.5M
 
Capital Expenditures -- -- -- -- $1.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$16.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$121.7K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $30.4M
 
Beginning Cash (CF) -- -- -- -- $57.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $20.4M
Ending Cash (CF) -- -- -- -- $78.4M
 
Levered Free Cash Flow -- -- -- -- $5.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$33.4M
Depreciation & Amoritzation -- -- -- -- $8.9M
Stock-Based Compensation -- -- -- -- $5.3M
Change in Accounts Receivable -- -- -- -- -$8.9M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- $2.8M
 
Capital Expenditures -- -- -- -- $3.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$28.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$577.6K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $79.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $53.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$1.1M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$103M -$11.2M -$158.7M -$33.4M --
Depreciation & Amoritzation $24.5M $19.6M $15.3M $8.9M --
Stock-Based Compensation $3.1M $4M $3.3M $5.3M --
Change in Accounts Receivable -$4.7M -$29.6M $1.6M -$8.9M --
Change in Inventories $14.9M -- -- -- --
Cash From Operations -$22.5M -$28.5M -$16M $2.8M --
 
Capital Expenditures $9.7M $38.3M $17M $3.9M --
Cash Acquisitions -$2M -$8.7M -- -- --
Cash From Investing -$90.7M $34.6M $4.8M -$28.5M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$91.8M -$796.1K -$436.5K -$577.6K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$66.8K -- -- --
Cash From Financing $137.5M $4.2M -$421.8K $79.2M --
 
Beginning Cash (CF) $192.6M $288.2M $148.6M $166.7M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $24.3M $10.3M -$11.6M $53.6M --
Ending Cash (CF) $217.5M $298M $136.6M $220.3M --
 
Levered Free Cash Flow -$32.2M -$66.8M -$33M -$1.1M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock